Report : Asia-Pacific Skin Graft Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Autologous, Allogeneic, Xenogeneic, Prosthetic, and Isogeneic), Graft Thickness (Split-Thickness, Full-Thickness, and Composite Graft), Application (Burns, Extensive Wound, Skin Cancer, and Other Applications), Equipment (Dermatome, General Surgical Instruments, Consumables, and Others), and End User (Ambulatory Surgical Centers, Hospitals, and Dermatology Clinics)

Burns Segment to Dominate APAC Skin Graft Market during 2020–2028

According to a new market research study on “APAC Skin Graft Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Graft thickness, Equipment, Application, and End user,” is expected to reach US$ 316.80 million by 2028 from US$ 181.81 million in 2021. The market is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The report provides trends prevailing in the APAC skin graft market along with the drivers and restraints pertaining to the market growth. Increasing prevalence of skin cancer and diabetes is the major factor driving the growth of the APAC skin graft market. However, alternatives for skin grafts hinders the growth of APAC skin graft market.

The outbreak of the COVID-19 pandemic has come from China. The spread of infection has affected various Asian countries such as India, South Korea, Australia, Malaysia, Singapore, and others. The countries have reported maximum deaths and laboratory diagnosed positive patients. Amid the second wave of COVID-19, India is experiencing the highest number of cases with lack of healthcare infrastructure. Therefore, various businesses and economies have dramatically affected, resulting in crises. The major focus has been shifted to treat COVID-19 affected patients and the production of personal equipment products. On the other hand, Asian countries have a maximum number of burn cases. Countries such as India, Nepal, and Pakistan have ~ 1 million cases for burn wounds. According to the WHO, an estimated 180 000 deaths every year are caused by burns – the vast majority occur in low- and middle-income countries. In addition, in India, the State-run Victoria hospital affiliated to the Bangalore Medical College and Research Institute (BMCRI) was converted into a dedicated COVID-19 facility ever since the pandemic hit Karnataka in March, the functioning of the Mahabodhi Burns Ward in the hospital has not been hit. Despite the pandemic, the hospital continued to operate normally, following all COVID-19 precautions. With only one skin donation, the hospital was able to graft patches of skin from the patients themselves. Therefore, the outbreak of the COVID-19 pandemic is estimated to affect skin grafts negatively. It is estimated that it will continue to affect negatively in the coming few years.

The market for skin graft market is segmented into product, graft thickness, equipment, application, end user and country. Based on product, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment held the largest share of the market. Based on graft thickness, the market is divided into split-thickness, full-thickness and composite graft. In 2020, the split thickness segment held the largest share of the market. Based on equipment, the market is segmented into dermatome, general surgical instruments, consumables, and others. In 2020, the dermatome segment held the largest share of the market. Based on application, the market is segmented into burns, extensive wound, skin cancer, and others. In 2020, the burns segment held the largest share of the market. Based on end user, the market is segmented into ambulatory surgical centers, hospitals and dermatology clinics. In 2020, the hospitals segment held the largest share of the market. Similarly, based on country, the market is bifurcated into China, Japan, India, South Korea, Australia, Rest of APAC. China contributed a substantial share in 2020. 

B. Braun Melsungen AG; Integra Life Sciences Corporation; MiMedx; Organogenesis Inc; Smith & Nephew; Zimmer Biomet; are among the leading companies in the APAC skin graft market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2019, Organogenesis, Inc.received contract for the PuraPly Antimicrobial (PuraPly AM), Apligraf, Dermagraft, NuShield and other products advanced wound care. Vizient, is one of the largest health care performance improvement company with over 3,100 hospital and health system members.

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: 

Download Free PDF Brochure